Peripheral artery disease trials in Brazil

In Brazil 7 Also abroad 233

7 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Where
Aracaju, Belém, Campinas, Goiânia, Porto Alegre, Ribeirão Preto, Tatuí
Age
18 years and over
People
1,205 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07223593 · EU 2025-523283-21-00
Phase 3Taking people
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Where
Blumenau, Campina Grande do Sul, Canoas, Dois Vizinhos, Goiânia, Matão, Ponta Grossa, Porto Alegre, São Paulo
Age
18 years and over
People
6,150 worldwide
Run by
Population Health Research Institute
See details and how to joinNCT04774159 · EU 2024-512091-35-01
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Belo Horizonte, Fortaleza, Goiânia, Joinville, Maringá, Natal, Passo Fundo, Porto Alegre, Praia Do Canto, Ribeirão Preto, Salvador, São José do Rio Preto, São Paulo
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
No phaseTaking people
Handgrip Training in Patients With Peripheral Artery Disease
Where
São Paulo
Age
45 years and over
People
30
Run by
University of Nove de Julho
See details and how to joinNCT03663777
No phaseEnrolling by invitation
Local or Systemic Effects: Mechanisms Related to Arm Crank Exercise - Comparison Between Individuals With and Without PAD
Where
São Paulo
Age
50 years and over
People
24
Run by
University of Nove de Julho
See details and how to joinNCT06828172
No phaseNot yet taking people in Brazil
General Versus Regional Anesthesia in Peripheral Arterial Surgery
Where
Porto Alegre
Age
18 years and over
People
594
Run by
Hospital de Clinicas de Porto Alegre
See details and how to joinNCT06953128
Phase 4Taking people
VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Where
Pernambuco
People
100
Run by
Science Valley Research Institute
See details and how to joinNCT06873321